Standard

Systematic review of current randomised control trials in chronic subdural haematoma and proposal for an international collaborative approach. / Edlmann, E.; Holl, D. C.; Lingsma, H. F. et al.

In: Acta neurochirurgica, Vol. 162, No. 4, 01.04.2020, p. 763-776.

Research output: Contribution to journalReview articleAcademicpeer-review

Harvard

Edlmann, E, Holl, DC, Lingsma, HF, Bartek, J, Bartley, A, Duerinck, J, Jensen, TSR, Soleman, J, Shanbhag, NC, Devi, BI, Laeke, T, Rubiano, AM, Fugleholm, K, van der Veken, J, Tisell, M, Hutchinson, PJ, Dammers, R, Kolias, AG, on behalf of the International Collaborative Research Initiative on Chronic Subdural Haematoma (iCORIC) study group, Edlmann, E, Iorio-Morin, C, Marshman, L, Poon, W, Smita, V, Sousa, S, Stienen, MN, Tian, Y, van der Gaag, NA & Verbaan, D 2020, 'Systematic review of current randomised control trials in chronic subdural haematoma and proposal for an international collaborative approach', Acta neurochirurgica, vol. 162, no. 4, pp. 763-776. https://doi.org/10.1007/s00701-020-04218-8

APA

Edlmann, E., Holl, D. C., Lingsma, H. F., Bartek, J., Bartley, A., Duerinck, J., Jensen, T. S. R., Soleman, J., Shanbhag, N. C., Devi, B. I., Laeke, T., Rubiano, A. M., Fugleholm, K., van der Veken, J., Tisell, M., Hutchinson, P. J., Dammers, R., Kolias, A. G., on behalf of the International Collaborative Research Initiative on Chronic Subdural Haematoma (iCORIC) study group, ... Verbaan, D. (2020). Systematic review of current randomised control trials in chronic subdural haematoma and proposal for an international collaborative approach. Acta neurochirurgica, 162(4), 763-776. https://doi.org/10.1007/s00701-020-04218-8

Vancouver

Edlmann E, Holl DC, Lingsma HF, Bartek J, Bartley A, Duerinck J et al. Systematic review of current randomised control trials in chronic subdural haematoma and proposal for an international collaborative approach. Acta neurochirurgica. 2020 Apr 1;162(4):763-776. doi: 10.1007/s00701-020-04218-8

Author

Edlmann, E. ; Holl, D. C. ; Lingsma, H. F. et al. / Systematic review of current randomised control trials in chronic subdural haematoma and proposal for an international collaborative approach. In: Acta neurochirurgica. 2020 ; Vol. 162, No. 4. pp. 763-776.

BibTeX

@article{82799481cdb84338a2ae6878fee6f485,
title = "Systematic review of current randomised control trials in chronic subdural haematoma and proposal for an international collaborative approach",
abstract = "Background: Chronic subdural haematoma (CSDH) is a pathology that is frequently encountered by neurosurgeons. Nevertheless, there is a lack of guidelines based on solid evidence. There has been a recent and considerable increase in the interest on management and outcomes for CSDH. Therefore, we systematically reviewed all currently running randomised controlled trials (RCTs) in chronic subdural haematoma to understand the areas under investigation and plan future collaborative trials. Methods: Clinical trials databases (Cochrane Controlled Register of Trials, WHO ICTRP and clinical trials.gov) were searched for trials relevant to chronic subdural haematoma. It was then established which trials were currently running and fulfilled robust research methodology for a RCT. Results: There are 26 currently running RCTs in CSDH, with the most common topics covering application of steroids (7), surgical techniques (5) and tranexamic acid (5). Further to this, there are trials running on other pharmacological agents (4), middle meningeal artery (MMA) embolisation (2) and peri-operative management (3). Conclusions: Pharmacological agents are a particular focus of CSDH management currently, and a wealth of studies on steroids will hopefully lead to more harmonised, evidence-based practice regarding this in the near future. Surgical techniques and new procedures such as MMA embolisation are also important focuses for improving patient outcomes. There is an on-going need for future RCTs and evidence-based guidelines in CSDH, particularly including low- and middle-income countries, and it is hoped that the establishment of the iCORIC (International COllaborative Research Initiative on Chronic Subdural Haematoma) will help address this.",
keywords = "Chronic subdural haematoma, Collaboration, Elderly, Head injury, Trials",
author = "E. Edlmann and Holl, {D. C.} and Lingsma, {H. F.} and J. Bartek and A. Bartley and J. Duerinck and Jensen, {T. S. R.} and J. Soleman and Shanbhag, {N. C.} and Devi, {B. Indira} and T. Laeke and Rubiano, {A. M.} and K. Fugleholm and {van der Veken}, J. and M. Tisell and Hutchinson, {P. J.} and R. Dammers and Kolias, {A. G.} and {on behalf of the International Collaborative Research Initiative on Chronic Subdural Haematoma (iCORIC) study group} and E. Edlmann and C. Iorio-Morin and L. Marshman and W. Poon and V. Smita and S. Sousa and Stienen, {M. N.} and Y. Tian and {van der Gaag}, {N. A.} and D. Verbaan",
year = "2020",
month = apr,
day = "1",
doi = "10.1007/s00701-020-04218-8",
language = "English",
volume = "162",
pages = "763--776",
journal = "Acta neurochirurgica",
issn = "0001-6268",
publisher = "Springer Wien",
number = "4",

}

RIS

TY - JOUR

T1 - Systematic review of current randomised control trials in chronic subdural haematoma and proposal for an international collaborative approach

AU - Edlmann, E.

AU - Holl, D. C.

AU - Lingsma, H. F.

AU - Bartek, J.

AU - Bartley, A.

AU - Duerinck, J.

AU - Jensen, T. S. R.

AU - Soleman, J.

AU - Shanbhag, N. C.

AU - Devi, B. Indira

AU - Laeke, T.

AU - Rubiano, A. M.

AU - Fugleholm, K.

AU - van der Veken, J.

AU - Tisell, M.

AU - Hutchinson, P. J.

AU - Dammers, R.

AU - Kolias, A. G.

AU - on behalf of the International Collaborative Research Initiative on Chronic Subdural Haematoma (iCORIC) study group

AU - Edlmann, E.

AU - Iorio-Morin, C.

AU - Marshman, L.

AU - Poon, W.

AU - Smita, V.

AU - Sousa, S.

AU - Stienen, M. N.

AU - Tian, Y.

AU - van der Gaag, N. A.

AU - Verbaan, D.

PY - 2020/4/1

Y1 - 2020/4/1

N2 - Background: Chronic subdural haematoma (CSDH) is a pathology that is frequently encountered by neurosurgeons. Nevertheless, there is a lack of guidelines based on solid evidence. There has been a recent and considerable increase in the interest on management and outcomes for CSDH. Therefore, we systematically reviewed all currently running randomised controlled trials (RCTs) in chronic subdural haematoma to understand the areas under investigation and plan future collaborative trials. Methods: Clinical trials databases (Cochrane Controlled Register of Trials, WHO ICTRP and clinical trials.gov) were searched for trials relevant to chronic subdural haematoma. It was then established which trials were currently running and fulfilled robust research methodology for a RCT. Results: There are 26 currently running RCTs in CSDH, with the most common topics covering application of steroids (7), surgical techniques (5) and tranexamic acid (5). Further to this, there are trials running on other pharmacological agents (4), middle meningeal artery (MMA) embolisation (2) and peri-operative management (3). Conclusions: Pharmacological agents are a particular focus of CSDH management currently, and a wealth of studies on steroids will hopefully lead to more harmonised, evidence-based practice regarding this in the near future. Surgical techniques and new procedures such as MMA embolisation are also important focuses for improving patient outcomes. There is an on-going need for future RCTs and evidence-based guidelines in CSDH, particularly including low- and middle-income countries, and it is hoped that the establishment of the iCORIC (International COllaborative Research Initiative on Chronic Subdural Haematoma) will help address this.

AB - Background: Chronic subdural haematoma (CSDH) is a pathology that is frequently encountered by neurosurgeons. Nevertheless, there is a lack of guidelines based on solid evidence. There has been a recent and considerable increase in the interest on management and outcomes for CSDH. Therefore, we systematically reviewed all currently running randomised controlled trials (RCTs) in chronic subdural haematoma to understand the areas under investigation and plan future collaborative trials. Methods: Clinical trials databases (Cochrane Controlled Register of Trials, WHO ICTRP and clinical trials.gov) were searched for trials relevant to chronic subdural haematoma. It was then established which trials were currently running and fulfilled robust research methodology for a RCT. Results: There are 26 currently running RCTs in CSDH, with the most common topics covering application of steroids (7), surgical techniques (5) and tranexamic acid (5). Further to this, there are trials running on other pharmacological agents (4), middle meningeal artery (MMA) embolisation (2) and peri-operative management (3). Conclusions: Pharmacological agents are a particular focus of CSDH management currently, and a wealth of studies on steroids will hopefully lead to more harmonised, evidence-based practice regarding this in the near future. Surgical techniques and new procedures such as MMA embolisation are also important focuses for improving patient outcomes. There is an on-going need for future RCTs and evidence-based guidelines in CSDH, particularly including low- and middle-income countries, and it is hoped that the establishment of the iCORIC (International COllaborative Research Initiative on Chronic Subdural Haematoma) will help address this.

KW - Chronic subdural haematoma

KW - Collaboration

KW - Elderly

KW - Head injury

KW - Trials

UR - http://www.scopus.com/inward/record.url?scp=85079506835&partnerID=8YFLogxK

U2 - 10.1007/s00701-020-04218-8

DO - 10.1007/s00701-020-04218-8

M3 - Review article

C2 - 32025806

VL - 162

SP - 763

EP - 776

JO - Acta neurochirurgica

JF - Acta neurochirurgica

SN - 0001-6268

IS - 4

ER -

ID: 10943386